Temple Sinai is graciously hosting this Oneinforty symposium to educate the community about Ashkenazi Jews’ one-in-forty risk of inheriting a BRCA gene mutation. People who have a BRCA mutation are at relatively high risk for developing ovarian, prostate and male and female breast cancer.
Come learn about genetic counseling, screening for BRCA mutations, misconceptions about hereditary cancer, how BRCA-positive individuals can manage their risk of developing cancer, emotional support resources available for you and your family and the BRCA Founder Outreach (BFOR) Study being conducted by Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Several people who are BRCA-positive will share their stories.
Following presentations by each of these panelists, there will be a Q&A session:
Betty Cooperstein, LICSW
In private practice in Brookline & Wayland
Founder & Executive Director
BRCA-positive ovarian cancer survivor
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Massachusetts General Hospital
Joi Morris, JD
Senior Vice President, Alliances & Legal Counsel
Director of National Outreach
This symposium is open to the general public. Kosher refreshments will be served.
Feel free to contact Lauren Corduck at email@example.com or 617-823-3630 with any questions you may have about the symposium.+ More... - Less...
* Registration closes on November 8th at 9:00 am
25 Canton Street
Sharon, MA 02067
CJP provides the above links concerning third-party events for your convenience only. CJP has no control over the content of the linked-to websites or events they describe, and accepts no responsibility for the websites, including any advertising or products or services on or available from such sites, or for any loss or damage that may arise from your attending, or registering to attend, the described events. If you decide to access any of the third-party websites linked to below, you do so entirely at your own risk and subject to the terms and conditions of use for such websites and event attendance. CJP is not responsible or liable to you or any third party for the content or accuracy of any materials provided by any third parties. All statements and/or opinions expressed in the linked-to materials or at the described events, and all commentary, articles and other content provided at the third-party websites or at the events, are solely the opinions and the responsibility of the persons or entities operating the linked-to websites and events. The inclusion of any link on this website does not imply that CJP endorses the described event, or the linked-to website or its operator.